sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present Extensive Research on Infectious Diseases
Moderna, Inc. (NASDAQ:MRNA) is set to present its latest research on various infectious diseases at the ESCMID Global Congress, held in Vienna from April 11-15, 2025. The focus will be on diseases such as COVID-19, influenza, RSV, CMV, norovirus, and mpox, showcasing the company's broad research efforts.
The event will include twelve presentations from Moderna, comprising three oral presentations and nine poster/e-poster presentations. Highlights include advancements in COVID-19 vaccine efficacy, RSV vaccine immunogenicity, and interim results from a novel mpox vaccine trial.
Presentations will cover topics from long-term vaccine safety to the immunogenicity of various mRNA-based vaccines, emphasizing Moderna's innovative approach to mRNA technology for disease prevention.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.